USA Today reports:
A new study found that the Johnson & Johnson COVID-19 vaccine serves as an effective booster on top of full vaccination from the Pfizer vaccine.
A J&J booster, administered six months after two doses of the Pfizer vaccine, increased antibody and T-cell responses, according to the study, demonstrating potential benefits of mix-and-match boosters.
“There is early evidence to suggest that a mix-and-match boosting approach may provide individuals with different immune responses against COVID-19 than a homologous boosting approach,” said Dan Barouch, director of the center for virology and vaccine research at the Beth Israel Deaconess Medical Center.
Read the full article.
A new study found that the Johnson & Johnson COVID vaccine serves as an effective booster on top of full vaccination from the Pfizer vaccine. It increased antibody and T-cell responses. https://t.co/qHSaCFrxHj
— Captivate (@Captivate) December 6, 2021